News

For patients undergoing noncardiac surgery, neurocognitive outcomes do not differ with hypotension-avoidance and hypertension-avoidance strategies.
The FDA has granted approval to pembrolizumab for the treatment of adult patients with resectable, locally advanced HNSCC ...
Brain Navi Biotechnology announced today that it received FDA 510(k) clearance for its NaoTrac stereotaxic guiding surgical ...
Cleveland Clinic patients who received the Ross procedure for aortic valve replacement after 2000 have experienced better outcomes than patients who received the procedure prior to 2000, according to ...
We are delighted that we have been awarded this designation,’' said Dr. Philip Otterbeck, RUMC’s chief medical officer.
An expert panel unveiled a preoperative cannabis use assessment tool to aid in planning informed, individualized anesthesia ...
HER2+ breast cancer usually undergo preoperative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery. A less intensive, reduced chemotherapy treatment ...
Virtual consultations hold the potential to transform patient care; however, their capacity to fully replace face-to-face interactions remains uncertain. ten Haaft and colleagues present findings from ...
For patients with a body mass index (BMI) of 70 or higher, metabolic surgery is a highly effective treatment for this form of ...
Merck & Co – known as MSD outside the US and Canada – has announced that its anti-PD-1 therapy Keytruda (pembrolizumab) has ...